New milestones in the therapy of chronic heart failure with betablockers;Neue meilensteine fur die therapie der chronischen herzinsuffizienz mit betablockern

Zeitschrift fur Kardiologie

Volumn 89, Issue 3, 2000, Pages 236-238

  Garlichs, C ^a   Daniel, W G ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Betablocker; Chronic heart failure; MERIT HF; Metoprolol

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; CATECHOLAMINE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INOTROPIC AGENT; METOPROLOL; PHOSPHODIESTERASE INHIBITOR; PLACEBO; CARBAZOLE DERIVATIVE; PROPANOLAMINE DERIVATIVE;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; TREATMENT OUTCOME; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DOUBLE BLIND PROCEDURE; MORTALITY; PATHOPHYSIOLOGY; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BISOPROLOL; CARBAZOLES; CARDIOMYOPATHY, DILATED; CONTROLLED CLINICAL TRIALS; DOUBLE-BLIND METHOD; HEART FAILURE, CONGESTIVE; HUMANS; METOPROLOL; PLACEBOS; PROGNOSIS; PROPANOLAMINES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS;

EID: 0033625202     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920050476     Document Type: Article

References (8)

1. 1. The Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group (1998) 3-year follow-up of patients randomised in the Metoprolol in Dilated Cardiomyopathy Trial. Lancet 351:1180-81
2. 2. CIBIS Investigators and Committees (1994) A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS) Circulation 90:1765-1773
3. 3. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, et al (1993) Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet 342:1441-1446
4. 4. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U. S. Carvedilol Heart Failure Study Group. N Engl J Med 334:1349-1355
5. 5. MERIT-HF Study Group (1997) Rationale, design, and organization of the Metoprolol CR/XL. Randomised Intervention Trial in Heart Failure (MERIT-HF). Am J Cardiol 80:54J-58J
6. 6. MERIT-HF Study Group (1999) Effect of Metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353:2001-2007
7. 7. CIBIS-II Investigators and Committees (1999) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353:9-13
8. Gheorghiade M, Bonow RO (1998) Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 97:282-289